Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-09-03

Clinical Trial Update: Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes [Phase 4]

View source ↗

Summary

Phase 4 study investigating losartan-based therapy in hypertensive patients, with and without diabetes, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan-based therapy (losartan)

Snippet

Sponsor: The University of The West Indies | Conditions: Diabetes Mellitus, Hypertension | Phase 4 | Status: WITHDRAWN